Skip to main content
Account

Peer review reports

From: The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial

Original Submission
27 Apr 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 May 2024 Reviewed Reviewer Report
30 May 2024 Reviewed Reviewer Report
10 Jun 2024 Author responded Author comments - Hourieh Ansari
Resubmission - Version 3
10 Jun 2024 Submitted Manuscript version 3
14 Jun 2024 Author responded Author comments - Hourieh Ansari
Resubmission - Version 4
14 Jun 2024 Submitted Manuscript version 4
19 Jun 2024 Author responded Author comments - Hourieh Ansari
Resubmission - Version 5
19 Jun 2024 Submitted Manuscript version 5
29 Jun 2024 Reviewed Reviewer Report
18 Aug 2024 Author responded Author comments - Hourieh Ansari
Resubmission - Version 6
18 Aug 2024 Submitted Manuscript version 6
Publishing
21 Aug 2024 Editorially accepted
4 Sep 2024 Article published 10.1186/s12906-024-04627-7

Learn about peer review

Back to article page

Navigation